Literature DB >> 27109109

Elusive treatment for human rhinosporidiosis.

Jeshina Janardhanan1, Shalom Patole1, Lalee Varghese1, V Rupa1, Amit Jiwan Tirkey1, George M Varghese2.   

Abstract

OBJECTIVES: The aim of this study was to clarify the contentious taxonomic classification of Rhinosporidium seeberi, the cause of human rhinosporidiosis, which may have treatment implications.
METHODS: PCR was used to amplify the internal transcribed spacer (ITS)-2 region from the genomic DNA of the aetiological agent obtained from a sample of human rhinosporidiosis lesions. The amplicon was sequenced and the organism identified using the Basic Local Alignment Search Tools (BLAST).
RESULTS: Phylogenetic analysis revealed that the aetiological agent clustered along with the R. seeberi isolated from humans and also with Amphibiocystidium ranae from frogs. This organism is a member of the order Dermocystida in the class Mesomycetozoea. A patient with disseminated rhinosporidiosis did not respond to conventional therapy with dapsone and surgical excision, and treatment with amphotericin B also proved futile.
CONCLUSION: An effective treatment for R. seeberi-a eukaryote belonging to the class Mesomycetozoea-is still elusive.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Amphotericin B; Mesomycetozoea; Rhinosporidiosis; Rhinosporidium seeberi

Mesh:

Substances:

Year:  2016        PMID: 27109109     DOI: 10.1016/j.ijid.2016.04.013

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  1 in total

1.  Lacrimal sac rhinosporidiosis: case report and review of literature with a new grading system to optimize treatment.

Authors:  Nishi Gupta; Poonam Singla; Bibhu Pradhan; Urmila Gurung
Journal:  Saudi J Ophthalmol       Date:  2019-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.